EMvision Medical Devices Ltd
ASX:EMV

Watchlist Manager
EMvision Medical Devices Ltd Logo
EMvision Medical Devices Ltd
ASX:EMV
Watchlist
Price: 1.95 AUD 2.09% Market Closed
Market Cap: 166.8m AUD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one EMV stock under the Base Case scenario is 0.26 AUD. Compared to the current market price of 1.95 AUD, EMvision Medical Devices Ltd is Overvalued by 87%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EMV Relative Value
Base Case
0.26 AUD
Overvaluation 87%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

19.3
P/S
P/S
Price to Sales
19.3
vs History
61
vs Industry
7
Median 3Y
18.7
Median 5Y
27.3
Industry
2.2
Forward
25.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-26.7
Median 5Y
-28.2
Industry
21.7
Forward
-21.2
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
1
Median 3Y
-31.6
Median 5Y
-41.8
Industry
13.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
1
Median 3Y
-28.9
Median 5Y
-39.1
Industry
18.9
More Details
10.8
P/B
P/B
Price to Book Value
10.8
vs History
77
vs Industry
5
Median 3Y
16.1
Median 5Y
16.9
Industry
2.1
More Details
18
EV/S
EV/S
Enterprise Value to Sales
18
vs History
63
vs Industry
7
Median 3Y
17.7
Median 5Y
25.9
Industry
2.3
Forward
23.5
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
4.7
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-28
Median 5Y
-26.6
Industry
11.4
Forward
-23.1
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-28
Median 5Y
-26.6
Industry
15.6
Forward
-22.6
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
1
Median 3Y
-30
Median 5Y
-39.7
Industry
13
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
1
Median 3Y
-28.5
Median 5Y
-37.3
Industry
16.5
More Details
30.4
EV/IC
EV/IC
Enterprise Value to IC
30.4
vs History
92
vs Industry
2
Median 3Y
89.9
Median 5Y
147.8
Industry
1.8
More Details

Multiples Across Competitors

EMV Competitors Multiples
EMvision Medical Devices Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
EMvision Medical Devices Ltd
ASX:EMV
166.8m AUD 19.3 -26.9 -29 -29
US
Abbott Laboratories
NYSE:ABT
220.8B USD 5.2 16.4 21.3 30.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
180.3B USD 20.7 73.1 58 69.8
US
Boston Scientific Corp
NYSE:BSX
149B USD 8.9 80.6 36.7 51.8
US
Stryker Corp
NYSE:SYK
137.4B USD 6.1 46.1 23.8 28.8
IE
Medtronic PLC
NYSE:MDT
107.6B USD 3.2 25.2 13.5 19.1
US
Becton Dickinson and Co
NYSE:BDX
58.8B USD 2.9 33.7 14.4 25.9
DE
Siemens Healthineers AG
XETRA:SHL
52.2B EUR 2.3 26.4 15.3 21.7
US
Edwards Lifesciences Corp
NYSE:EW
44.5B USD 8.2 10.6 25.1 27.8
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
263.1B CNY 7.1 21.2 18.4 18.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
35.5B USD 9.1 39.9 28.4 31.7

See Also

Summary
EMV intrinsic value, competitors valuation, and company profile.
DCF Valuation
EMV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EMV stock valuation using valuation multiples.
Wall Street Estimates
EMV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EMV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 248,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.